TheEdgeResearch
Home / Stocks / CSTF

CuraScientific Corp (CSTF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$377,345
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-3.96
52-Wk Range
0.0001-0.0001
CEO
Samuel L. Berry
Country
US
Currency
USD

CuraScientific Corp operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Coachella, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $377,345. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -15299.2%. Its beta of -3.96 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
10.96
Price / Book
-0.00
EV / EBITDA
-0.88
Gross margin
-3298.1%
Operating margin
-6910.9%
Net margin
-15299.2%
Return on equity
Debt / equity
-0.04
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
1998-01-08
Headquarters
Coachella, CA, US
About CuraScientific Corp

Based in Coachella, California, CuraScientific Corp. was founded in 2020. The company focuses on the production, distribution, and retail of cannabis products, which are sold under the JW Brands and Chad Enterprises names. In addition to cannabis, its offerings extend to cannabidiol (CBD), kava, and kratom. Prior to April 2023, the company operated as Boon Industries, Inc. before adopting its current name.

Comparable companies

CuraScientific Corp is most often compared with the following Healthcare names:

CNNXFERBBGRVEINSOLVTTFMGWFFSKYISNNCSTSNTMSH
More research on CSTF
CSTF technical analysis CSTF TheEdge Score Compare against peers
Open full interactive analysis & DCF →